Location History:
- Laval, CA (2012)
- Rixensart, BE (2008 - 2014)
Company Filing History:
Years Active: 2008-2014
Title: Innovator Spotlight: Remi Palmantier
Introduction: Remi Palmantier is a prominent inventor based in Rixensart, Belgium, with a noteworthy portfolio including three patents. Her contributions to the field of biotechnology have garnered attention and recognition, particularly in the context of vaccine development.
Latest Patents: Among her latest patents are the CASB7439 constructs, which relate to compounds and methods aimed at enhancing the recombinant production of CASB7439 polypeptides. This innovation holdspotential for advancing biopharmaceutical production. Another significant patent involves the creation of fusion proteins that comprise an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1. These fusion proteins, which may include various carriers and fusion partners, are designed for use as vaccine components intended to induce immune responses against cancer-antigen-bearing cells.
Career Highlights: Remi currently works at GlaxoSmithKline Biologicals SA, a leading biopharmaceutical company recognized for its commitment to improving health through innovative medicines. Her role involves pioneering research that bridges the gap between fundamental science and practical applications in immunotherapy.
Collaborations: Throughout her career, Remi has collaborated with notable colleagues such as Normand Blais and Clement Rioux. These partnerships emphasize the importance of teamwork in the research and innovation process, leading to impactful developments in the medical field.
Conclusion: Remi Palmantier’s contributions as an inventor are significant in the evolving landscape of biopharmaceuticals. Her latest patents and collaborations underscore her commitment to advancing therapeutic technologies, as she continues to make strides in the fight against cancer and improve health outcomes globally.